HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis

被引:41
作者
Ford, Nathan [1 ,2 ]
Orrell, Catherine [3 ,4 ]
Shubber, Zara [5 ]
Apollo, Tsitsi [6 ]
Vojnov, Lara [1 ]
机构
[1] World Hlth Org, Dept HIV, Geneva, Switzerland
[2] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa
[3] Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, Cape Town, South Africa
[4] Univ Cape Town, Dept Med, Cape Town, South Africa
[5] Imperial Coll London, Dept Infect Dis Epidemiol, London, England
[6] Govt Zimbabwe, Minist Hlth & Child Care, AIDS & TB Unit, Harare, Zimbabwe
基金
比尔及梅琳达.盖茨基金会;
关键词
adherence; enhanced adherence counselling; elevated viral load; viral suppression; viral resuppression; 1ST-LINE ANTIRETROVIRAL TREATMENT; ADHERENCE; CHILDREN; THERAPY; REGIMEN;
D O I
10.1002/jia2.25415
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction Guidelines for antiretroviral therapy recommend enhanced adherence counselling be provided to individuals with an initial elevated viral load before making a decision whether to switch antiretroviral regimen. We undertook this systematic review to estimate the proportion of patients with an initial elevated viral load who resuppress following enhanced adherence counselling. Methods Two databases and two conference abstract sites were searched from January 2012 to October 2019 for studies reporting the number of patients with an elevated viral load whose viral load was undetectable when subsequently assessed. Data were pooled using random effects meta-analysis. Results Fifty-eight studies reported outcomes of 45,720 viraemic patients, mostly from Africa (48 studies), and among patients on first-line antiretroviral therapy (43 studies). Almost half (46.1%, 95% CI 42.6% to 49.5%) of patients with an initial elevated viral load resuppressed following an enhanced adherence intervention. Of those on first-line ART with confirmed virological failure (6280 patients, 21 studies), only 53.4% (40.1% to 66.8%) were appropriately switched to a different regimen. Resuppression was higher among studies that provided details of adherence support. The proportion resuppressing was lower among children (31.2%, 21.1% to 41.3%) and adolescents (40.4%, 15.7% to 65.2%) compared to adults (50.4%, 42.6% to 58.3%). No important differences were observed by date of study publication, gender, viral failure threshold, publication status, time between viral loads or treatment regimen. Information on resistance testing among people with an elevated viral load was inconsistently reported. Conclusions The findings of this review suggest that in settings with limited resources, current guideline recommendations to provide enhanced adherence counselling can result in resuppression of a substantial number of these patients, avoiding unnecessary drug regimen changes. Appropriate action on viral load results is limited across a range of settings, highlighting the importance of viral load cascade analyses to identify gaps and focus quality improvement to ensure that action is taken on the results of viral load testing.
引用
收藏
页数:6
相关论文
共 31 条
[1]  
[Anonymous], 2016, MAK VIR LOAD ROUT SU
[2]   Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda [J].
Billioux, Alexander ;
Nakigozi, Gertrude ;
Newell, Kevin ;
Chang, Larry W. ;
Quinn, Thomas C. ;
Gray, Ron H. ;
Ndyanabo, Anthony ;
Galiwango, Ronald ;
Kiggundu, Valerian ;
Serwadda, David ;
Reynolds, Steven J. .
PLOS ONE, 2015, 10 (05)
[3]  
Bodo C, 2019, C RETR OPP INF SEATT
[4]  
Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac
[5]   Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues [J].
Bvochora, Talent ;
Satyanarayana, Srinath ;
Takarinda, Kudakwashe C. ;
Bara, Hilda ;
Chonzi, Prosper ;
Komtenza, Brian ;
Duri, Clemence ;
Apollo, Tsitsi .
PLOS ONE, 2019, 14 (02)
[6]   Outcomes after viral load rebound on first-line antiretroviral treatment in children with HIV in the UK and Ireland: an observational cohort study [J].
Childs, Tristan ;
Shingadia, Delane ;
Goodall, Ruth ;
Doerholt, Katja ;
Lyall, Hermione ;
Duong, Trinh ;
Judd, Ali ;
Gibb, Di M. ;
Collins, Intira Jeannie .
LANCET HIV, 2015, 2 (04) :E151-E158
[7]   Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study [J].
Eholie, Serge P. ;
Moh, Raoul ;
Benalycherif, Aida ;
Gabillard, Delphine ;
Ello, Frederic ;
Messou, Eugene ;
Zoungrana, Jacques ;
Diallo, Ismael ;
Diallo, Mouhamadou ;
Bado, Guillaume ;
Cisse, Mamadou ;
Maiga, Almoustapha I. ;
Anzian, Amani ;
Toni, Thomas-d'Aquin ;
Congo-Ouedraogo, Malika ;
Toure-Kane, Coumba ;
Seydi, Moussa ;
Minta, Daouda K. ;
Sawadogo, Adrien ;
Sangare, Lassana ;
Drabo, Joseph ;
Karcher, Sophie ;
Le Carrou, Jerome ;
de Monteynard, Laure-Amelie ;
Peytavin, Gilles ;
Gabassi, Audrey ;
Girard, Pierre-Marie ;
Chaix, Marie-Laure ;
Anglaret, Xavier ;
Landman, Roland .
LANCET HIV, 2019, 6 (11) :E750-E759
[8]   Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland [J].
Etoori, David ;
Ciglenecki, Iza ;
Ndlangamandla, Mpumelelo ;
Edwards, Celeste G. ;
Jobanputra, Kiran ;
Pasipamire, Munyaradzi ;
Maphalala, Gugu ;
Yang, Chunfu ;
Zabsonre, Inoussa ;
Kabore, Serge M. ;
Goiri, Javier ;
Teck, Roger ;
Kerschberger, Bernhard .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 (10)
[9]   Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa [J].
Evans, Denise ;
Berhanu, Rebecca ;
Moyo, Faith ;
Nguweneza, Arthemon ;
Long, Lawrence ;
Fox, Matthew P. .
AIDS AND BEHAVIOR, 2016, 20 (11) :2717-2728
[10]  
Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202